MedPath
FDA Approval

Fexinidazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fexinidazole(600 mg in 1 1)

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

EUROAPI Hungary Ltd.

Sanofi-Aventis U.S. LLC

402388457

Alcami Carolinas Corporation

Sanofi-Aventis U.S. LLC

831351445

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fexinidazole

Product Details

NDC Product Code
0024-4512
Application Number
NDA214429
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
January 4, 2023
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141JClass: IACT
Code: 306ERL82IRClass: ACTIBQuantity: 600 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath